No phaseStatus unknown
A Single-Arm, Open-Label, Prospective, Pre-Post Clinical Study to Evaluate the Effect of Mazdutide on the Annualized Gout Flare Rate in Adults with Obesity and Comorbid Gout
- Sponsor
- The First Affiliated Hospital of Henan University of Science and Technology
- Enrolment
- 30 planned
- Conditions
- Obesity/Gout
- Interventions
- Subjects will receive Mazdutide injection administered subcutaneously once weekly
- Ages
- adults, older adults
- Registry
- ChiCTR2600131243
Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed 7 September 2026
Primary outcomes
- Annualized Gout Flare Rate (AFR);
History
Last registry update
Started
Registered